Kassubek, J, Factor, SA, Balaguer, E, Schwarz, J, Chaudhuri, KR, Isaacson, SH, Wu, S, Muhr, CD, Kulisevsky, J. Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. JOURNAL OF NEUROLOGY. 2024; 271(6)DOI:10.1007/s00415-024-12323-2. PMID:38546829. IF:4.600(Q1/2D).

Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Sampedro, F, Horta-Barba, A, Campolongo, A, Rivas-Asensio, E, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. 2024; 11(5)DOI:10.1002/acn3.52031. PMID:38544341. IF:3.900(Q1/3D).

Garon, M, Weis, L, Siquier, A, Fiorenzato, E, Pistonesi, F, Cianci, V, Canesi, M, Pesce, F, Reali, E, Pozzi, B, Isaias, IU, Siri, C, Santangelo, G, Cuoco, S, Barone, P, Kulisevsky, J, Antonini, A, Biundo, R. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(4)DOI:10.1007/s00702-024-02746-6. PMID:38280057. IF:4.000(Q1/2D).

Pagonabarraga, J, Bejr-Kasem, H, Martinez-Horta, S, Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nature Reviews Neurology. 2024; 20(3)DOI:10.1038/s41582-023-00918-8. PMID:38225264. IF:33.100(Q1/1D).